HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Megumi Yamada Selected Research

1- nitro- 9- (5- dimethylaminopentylamino)anthracene dihydrochloride

4/2019Novel PHOX2B mutations in congenital central hypoventilation syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Megumi Yamada Research Topics

Disease

3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
02/2020 - 04/2011
2Deglutition Disorders (Dysphagia)
12/2023 - 12/2020
2Stroke (Strokes)
02/2021 - 02/2010
2Fahr's disease
01/2018 - 05/2010
2Alzheimer Disease (Alzheimer's Disease)
01/2012 - 04/2011
2Parkinson Disease (Parkinson's Disease)
04/2011 - 03/2011
1MELAS Syndrome (Syndrome, MELAS)
02/2021
1Myelitis
11/2020
1Corticobasal Degeneration
07/2020
1Headache (Headaches)
02/2020
1Brain Abscess (Abscess, Brain)
02/2020
1Pain (Aches)
02/2020
1Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
01/2020
1Neoplasms (Cancer)
04/2019
1Sporadic Creutzfeldt-Jakob Disease
11/2017
1Hashimoto's encephalitis
11/2017
1Encephalitis (Encephalitis, Rasmussen)
07/2017
1Neuralgia (Stump Neuralgia)
07/2017
1Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
11/2016
1Tremor (Tremors)
01/2016
1Hypertension (High Blood Pressure)
01/2016
1Constipation
01/2016
1Bipolar Disorder (Manic Depressive Psychosis)
01/2016
1Essential Hypertension
01/2016
1Diarrhea
01/2016
1Cerebral Small Vessel Diseases
11/2012
1Inflammation (Inflammations)
11/2012
1Atherosclerosis
05/2012
1Coronary Artery Disease (Coronary Atherosclerosis)
05/2012
1Cognitive Dysfunction
01/2012
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2011
1Multiple Sclerosis
04/2011
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2011
1Parkinsonian Disorders (Parkinsonism)
05/2010
1Hydrocephalus (Hydrocephaly)
05/2010
1Disease Progression
04/2010
1Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
04/2010
1Polyneuropathies (Polyneuropathy)
04/2010
1Muscular Dystrophies (Muscular Dystrophy)
02/2002
1Hypertrophy
02/2002

Drug/Important Bio-Agent (IBA)

5AntibodiesIBA
07/2020 - 04/2011
3ZincIBA
04/2011 - 02/2002
2CalciumIBA
01/2018 - 05/2010
2Intravenous Immunoglobulins (IVIG)FDA Link
07/2017 - 04/2010
2CopperIBA
04/2011 - 05/2010
2MagnesiumIBA
04/2011 - 05/2010
2IronIBA
04/2011 - 05/2010
1BenzodiazepinesIBA
12/2023
1Arginine (L-Arginine)FDA Link
02/2021
1Glial Fibrillary Acidic ProteinIBA
11/2020
1DNA Transposable Elements (Element, IS)IBA
01/2020
1TESIBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
11- nitro- 9- (5- dimethylaminopentylamino)anthracene dihydrochlorideIBA
04/2019
1Phosphates (Orthophosphate)IBA
01/2018
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2017
1Phosphopyruvate Hydratase (Enolase)IBA
11/2017
1SteroidsIBA
07/2017
1Codon (Codons)IBA
11/2016
1Isoleucine (L-Isoleucine)FDA Link
11/2016
1Valine (L-Valine)FDA Link
11/2016
1Lithium Carbonate (Eskalith)FDA LinkGeneric
01/2016
1AngiotensinsIBA
01/2016
1Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2016
1Angiotensin Receptor AntagonistsIBA
01/2016
1Antihypertensive Agents (Antihypertensives)IBA
01/2016
1azilsartanIBA
01/2016
1LithiumIBA
01/2016
13-Iodobenzylguanidine (Iobenguane)IBA
09/2013
1Chaperonin 60IBA
05/2012
1ManganeseIBA
04/2011
1Biomarkers (Surrogate Marker)IBA
04/2011
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
04/2011
1SynucleinsIBA
03/2011
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2011
1Levodopa (L Dopa)FDA LinkGeneric
05/2010
1fluorodopa F 18IBA
05/2010
1polaprezinc (Z 103)IBA
02/2002
1AntioxidantsIBA
02/2002

Therapy/Procedure

2Therapeutics
02/2021 - 04/2010
1Gastrostomy
12/2020
1Artificial Respiration (Mechanical Ventilation)
02/2020
1Aftercare (After-Treatment)
04/2010
1Plasmapheresis
04/2010
1Activities of Daily Living (ADL)
02/2010